Robert Berman, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 35,000 shares at $27.09 ($963K) on 2018-01-10, disclosed to the SEC on 2018-01-12.
Open-market sale of $963k BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.09 | 4,945 | $134K | 13.9% |
| 2 | $27.09 | 19,780 | $536K | 55.6% |
| 3 | $28.29 | 6,300 | $178K | 18.5% |
| 4 | $28.29 | 1,575 | $45K | 4.6% |
| 5 | $29.37 | 1,840 | $54K | 5.6% |
| 6 | $29.37 | 460 |
| $14K |
| 1.4% |
| 7 | $29.98 | 20 | $600 | 0.1% |
| 8 | $29.98 | 80 | $2K | 0.2% |
| Total | $27.52 avg | 35,000 | $963K | 100% |
| Filing → |
| BHVN | SELL | 2020-06-22 | $9.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $13.3M | — | Filing → |
| BHVN | BUY | 2019-06-28 | $106K | — | Filing → |